SEC Form 4 · accession 0001209191-17-042498
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric Sullivan
Officer — Principal Accounting Officer
Period of report
Jun 29, 2017
Accepted (ET)
Jun 30, 2017 · 4:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 29, 2017 | M | 2,000 | $20.70 | A | 8,466 | D | |
| Common Stock | Jun 29, 2017 | M | 1,298 | $24.47 | A | 9,764 | D | |
| Common Stock | Jun 29, 2017 | M | 3,430 | $50.51 | A | 13,194 | D | |
| Common StockF1 | Jun 29, 2017 | S | 3,293 | $108.0204 | D | 9,901 | D | |
| Common StockF2 | Jun 29, 2017 | S | 1,611 | $109.4143 | D | 8,290 | D | |
| Common StockF3 | Jun 29, 2017 | S | 1,824 | $110.2784 | D | 6,466 | D | |
| Common Stock | Jun 29, 2017 | S | 59 | $108.55 | D | 6,407 | D | |
| Common StockF4 | holding | — | — | — | 300 | I | By spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F5 | $20.70 | Jun 29, 2017 | M | 2,000 | D | — | Dec 2, 2023 | Common Stock | 2,000 | 1,250 | D |
| Stock Option (right to buy)F6 | $24.47 | Jun 29, 2017 | M | 1,298 | D | — | Mar 3, 2024 | Common Stock | 1,298 | 1,216 | D |
| Stock Option (right to buy)F7 | $50.51 | Jun 29, 2017 | M | 3,430 | D | — | Mar 1, 2026 | Common Stock | 3,430 | 6,270 | D |
Explanation of responses
- F1The range in prices for the transaction reported on this line was $108.00 to $108.15. The average weighted price was $108.0204. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F2The range in prices for the transaction reported on this line was $109.00 to $109.50. The average weighted price was $109.4143. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3The range in prices for the transaction reported on this line was $110.00 to $110.95. The average weighted price was $110.2784. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4Equity grants held by the reporting person's spouse, who is employed by the issuer
- F5This option vests over a four-year period, at a rate of twenty-five percent(25%) on November 11, 2014 and in 36 equal monthly installments thereafter.
- F6This option vests over a four-year period, at a rate of twenty-five percent(25%) on January 1, 2015 and in 36 equal monthly installments thereafter.
- F7This option vests over a four-year period, at a rate of twenty-five percent (25%) on January 4, 2017, and in 36 equal monthly installments.